Angkana Chaiprasert Selected Research

Angkana Chaiprasert Research Topics

Disease

14	Tuberculosis (Tuberculoses) 01/2022 - 04/2009
10	Extensively Drug-Resistant Tuberculosis 12/2022 - 02/2009
10	Infections 01/2021 - 08/2002
7	Pythiosis 01/2019 - 09/2004
6	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2018 - 02/2009
2	Starvation 01/2022 - 01/2021
2	Thalassemia 01/2019 - 05/2006
2	Necrosis 12/2016 - 06/2014
1	beta-Thalassemia (Cooley's Anemia) 01/2019
1	Iron Overload 01/2019
1	Mycetoma 12/2016
1	Chromoblastomycosis (Chromomycosis) 12/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2016
1	Blindness (Hysterical Blindness) 09/2016
1	Endophthalmitis (Ophthalmia) 09/2016
1	Persistent Infection 01/2016
1	Reinfection 01/2016
1	Noncommunicable Diseases 01/2015
1	Keratitis 01/2014
1	Melioidosis 12/2006
1	Vascular Diseases (Vascular Disease) 09/2006
1	Communicable Diseases (Infectious Diseases) 05/2006
1	Arteritis 05/2006
1	Ulcer 05/2006
1	Tinea Capitis 11/2005
1	Granuloma 01/2005
1	Inflammation (Inflammations) 06/2004
1	Pleurisy (Pleuritis) 03/2004
1	Malignant Pleural Effusion 03/2004
1	Pleural Effusion (Pleural Effusions) 03/2004
1	Pulmonary Tuberculosis 12/2003

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 12/2022 - 02/2009
4	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 03/2007
3	CytokinesIBA 01/2019 - 06/2014
3	Kanamycin FDA Link 07/2018 - 06/2014
3	QuinolonesIBA 01/2018 - 06/2015
3	ParaffinIBA 12/2016 - 01/2005
2	Linezolid (Zyvox)FDA Link 12/2022 - 02/2009
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Amikacin (A.M.K)FDA LinkGeneric 07/2018 - 06/2014
2	resazurinIBA 01/2018 - 09/2017
2	VaccinesIBA 12/2014 - 05/2006
2	AntigensIBA 05/2006 - 09/2004
2	AcidsIBA 06/2004 - 12/2003
1	Cycloserine (Seromycin)FDA Link 12/2022
1	Clofazimine (Lamprene)FDA Link 12/2022
1	bedaquiline (R207910)IBA 12/2022
1	OPC-67683IBA 12/2022
1	pretomanidIBA 12/2022
1	NADPH Oxidase 2IBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	CholesterolIBA 01/2021
1	Toll-Like Receptor 2IBA 06/2020
1	Neutralizing AntibodiesIBA 06/2020
1	IronIBA 01/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2019
1	Chelating AgentsIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 09/2018
1	AminoglycosidesIBA 07/2018
1	Plant ExtractsIBA 09/2017
1	1'-acetoxychavicol acetateIBA 09/2017
1	Actins (F Actin)IBA 12/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2016
1	Interferon-gamma (Interferon, gamma)IBA 12/2016
1	Antimicrobial PeptidesIBA 12/2016
1	Anti-Infective Agents (Microbicides)IBA 09/2016
1	Staphylococcal Protein A (Protein A)IBA 08/2016
1	N 30IBA 01/2016
1	AT 61IBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	DNA GyraseIBA 01/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Nucleic AcidsIBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	ProteomeIBA 01/2015
1	Capreomycin (Capastat)FDA Link 06/2014
1	A-Form DNA (A-DNA)IBA 06/2014
1	EnzymesIBA 05/2013
1	ImmunosorbentsIBA 05/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011
1	pyrazinamide deamidaseIBA 08/2010
1	Immunoglobulin M (IgM)IBA 12/2006
1	Immunoglobulin G (IgG)IBA 12/2006
1	Immunodominant EpitopesIBA 05/2006
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2005
1	C-Reactive ProteinIBA 03/2004
1	tributyl phosphate (TBP)IBA 03/2004

Therapy/Procedure

3	Therapeutics 01/2015 - 08/2002
2	Injections 07/2018 - 06/2014
2	Surgical Amputation (Amputations) 09/2006 - 05/2006
1	Debridement 05/2013
1	Treatment Delay 09/2006
1	Duration of Therapy 11/2005
1	Immunotherapy 09/2004